M
M'Liss A. Hudson
Researcher at Washington University in St. Louis
Publications - 42
Citations - 4394
M'Liss A. Hudson is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Prostate & Prostate-specific antigen. The author has an hindex of 23, co-authored 41 publications receiving 4327 citations. Previous affiliations of M'Liss A. Hudson include University of Texas Health Science Center at San Antonio & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
William J. Catalona,Jerome P. Richie,Frederick R. Ahmann,M'Liss A. Hudson,Peter T. Scardino,Robert C. Flanigan,Jean B. deKernion,Timothy L. Ratliff,Louis R. Kavoussi,Bruce L. Dalkin,W. Bedford Waters,Michael T. Macfarlane,Paula C. Southwick +12 more
TL;DR: In this paper, a prospective clinical trial at 6 university centers of 6,630 male volunteers 50 years old or older who underwent PSA determination (Hybritech Tandom-E or Tandem-R assays) and digital rectal examination was conducted.
Journal ArticleDOI
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
TL;DR: It is concluded that the serum prostate specific antigen assay is most useful clinically to monitor the response to therapy of prostate cancer patients.
Journal ArticleDOI
Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer
TL;DR: The results suggest that patients who have failed 2 courses of bacillus Calmette-Guerin therapy (as given in the treatment protocol) should be considered for alternative treatment.
Journal ArticleDOI
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination
Jerome P. Richie,William J. Catalona,Frederick R. Ahmann,M'Liss A. Hudson,Peter T. Scardino,Robert C. Flanigan,Jean B. deKernion,Timothy L. Ratliff,Louis R. Kavoussi,Bruce L. Dalkin,W. Bedford Waters,Michael T. Macfarlane,Paula C. Southwick +12 more
TL;DR: The use of both tests in combination provided the highest rate of detection in all age groups, and younger men have the longest projected life expectancy and, therefore, the most to gain from early prostate cancer detection.
Journal ArticleDOI
Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer
Michael F. Sarosdy,R.W. deVere White,M.S. Soloway,Joel Sheinfeld,M'Liss A. Hudson,P.F. Schellhammer,M.V. Jarowenko,G. Adams,B.A. Blumenstein +8 more
TL;DR: The bladder tumor antigen test is a simple, rapid and inexpensive adjunct to cystoscopy, and the results are equivalent or superior to those of voided cytology as performed in this trial.